ASPN Q1 2026 Earnings EPS Misses Consensus Stock Climbs 585 on Strategic Momentum NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 SY Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment as Revenue Remains Under Wraps KMT Q1 2026 Earnings Earnings Beat Estimates by 1345 Shares Edge Higher RPT Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges CMS Q1 2026 Earnings Slight EPS Beat Amid Steady Utility Operations